A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT05201248 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05201248
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-10
- Primary completion
- 2025-04-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.